Renaissance Technologies (RenTech)'s NHI Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 41,699 shares of National Health Investors, Inc. (NHI) worth $3.37 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in NHI, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 319,360 shares. Largest reduction occurred in Q2 2020, reducing 362,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s National Health Investors (NHI) Holding Value Over Time
Track share changes against reported price movement
Quarterly National Health Investors (NHI) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +41,699 | New Buy | 41,699 | $80.86 |
| Q4 2025 | -18,400 | Sold Out | 0 | $0.00 |
| Q3 2025 | -22,100 | Reduce 54.57% | 18,400 | $79.50 |
| Q2 2025 | +40,500 | New Buy | 40,500 | $70.12 |
| Q1 2025 | -30,500 | Sold Out | 0 | $0.00 |
| Q4 2024 | -51,700 | Reduce 62.90% | 30,500 | $69.30 |
| Q3 2024 | +700 | Add 0.86% | 82,200 | $84.06 |
| Q2 2024 | -2,000 | Reduce 2.40% | 81,500 | $67.73 |
| Q1 2024 | +18,200 | Add 27.87% | 83,500 | $62.83 |
| Q4 2023 | +4,400 | Add 7.22% | 65,300 | $55.85 |
| Q3 2023 | -46,600 | Reduce 43.35% | 60,900 | $51.36 |
| Q2 2023 | +9,000 | Add 9.14% | 107,500 | $0.05 |
| Q1 2023 | -29,324 | Reduce 22.94% | 98,500 | $0.05 |
| Q4 2022 | +127,824 | New Buy | 127,824 | $0.05 |
| Q2 2022 | -70,000 | Sold Out | 0 | $0.00 |
| Q1 2022 | +70,000 | New Buy | 70,000 | $59.01 |
| Q4 2021 | -50,900 | Sold Out | 0 | $0.00 |
| Q3 2021 | -1,000 | Reduce 1.93% | 50,900 | $53.50 |
| Q2 2021 | +51,900 | New Buy | 51,900 | $67.05 |
| Q1 2021 | -66,590 | Sold Out | 0 | $0.00 |
| Q4 2020 | -293,910 | Reduce 81.53% | 66,590 | $69.17 |
| Q3 2020 | -295,500 | Reduce 45.05% | 360,500 | $60.27 |
| Q2 2020 | -362,200 | Reduce 35.57% | 656,000 | $60.72 |
| Q1 2020 | +119,100 | Add 13.25% | 1.02 M | $49.52 |
| Q4 2019 | -14,400 | Reduce 1.58% | 899,100 | $81.48 |
| Q3 2019 | +21,000 | Add 2.35% | 913,500 | $82.39 |
| Q2 2019 | -118,800 | Reduce 11.75% | 892,500 | $78.03 |
| Q1 2019 | +55,700 | Add 5.83% | 1.01 M | $78.55 |
| Q4 2018 | +319,360 | Add 50.19% | 955,600 | $75.54 |
| Q3 2018 | +155,940 | Add 32.47% | 636,240 | $75.59 |
| Q2 2018 | -77,700 | Reduce 13.92% | 480,300 | $73.68 |
| Q1 2018 | +86,300 | Add 18.30% | 558,000 | $67.29 |
| Q4 2017 | +110,000 | Add 30.41% | 471,700 | $75.38 |
| Q3 2017 | +226,100 | Add 166.74% | 361,700 | $77.29 |
| Q2 2017 | +69,567 | Add 105.35% | 135,600 | $79.20 |
| Q1 2017 | +66,033 | New Buy | 66,033 | $72.63 |
| Q4 2016 | -28,100 | Sold Out | 0 | $0.00 |
| Q3 2016 | +28,100 | New Buy | 28,100 | $78.47 |
| Q2 2016 | -8,300 | Sold Out | 0 | $0.00 |
| Q1 2016 | -40,200 | Reduce 82.89% | 8,300 | $66.51 |
| Q4 2015 | -93,700 | Reduce 65.89% | 48,500 | $60.87 |
| Q3 2015 | +32,800 | Add 29.98% | 142,200 | $57.49 |
| Q2 2015 | +83,400 | Add 320.77% | 109,400 | $62.30 |
| Q1 2015 | +26,000 | New Buy | 26,000 | $71.00 |
| Q1 2014 | -146,716 | Sold Out | 0 | $0.00 |
| Q4 2013 | -42,084 | Reduce 22.29% | 146,716 | $56.10 |
| Q3 2013 | -22,695 | Reduce 10.73% | 188,800 | $56.89 |
| Q2 2013 | +211,495 | Add 0.00% | 211,495 | $59.86 |
Renaissance Technologies (RenTech)'s National Health Investors Investment FAQs
Renaissance Technologies (RenTech) first purchased National Health Investors, Inc. (NHI) in Q2 2013, acquiring 211,495 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held National Health Investors, Inc. (NHI) for 48 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to National Health Investors, Inc. (NHI) was in Q4 2018, adding 955,600 shares worth $72.19 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 41,699 shares of National Health Investors, Inc. (NHI), valued at approximately $3.37 M.
As of the Q1 2026 filing, National Health Investors, Inc. (NHI) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in National Health Investors, Inc. (NHI) was 1,018,200 shares, as reported at the end of Q1 2020.